Mutation Analysis of Isocitrate Dehydrogenase in Acute Lymphoblastic Leukemia

Abstract

The results suggested that the IDH1 R132 mutation might be a recurrent gene alteration in ALL; patients carrying the mutation have a trend to aberrantly express myeloid antigen and the mutation may imply a dismal outcome.